Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Renal insufficiency has no effect on the pharmacokinetics of vicriviroc in a ritonavir-containing regimen.

Kasserra C, Sansone-Parsons A, Keung A, Tetteh E, Assaf M, O'Mara E, Marbury T.

Clin Pharmacokinet. 2010 Jun;49(6):397-406. doi: 10.2165/11319470-000000000-00000.

PMID:
20481650
2.

Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable.

Fätkenheuer G, Hoffmann C, Slim J, Rouzier R, Keung A, Li J, Treitel M, Sansone-Parsons A, Kasserra C, O'Mara E, Schürmann D.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):78-85. doi: 10.1097/QAI.0b013e3181bb28dc.

PMID:
19838130
3.

Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.

Krishna G, Sansone-Parsons A, Kantesaria B.

Curr Med Res Opin. 2007 Jun;23(6):1415-22. Epub 2007 May 11.

PMID:
17559737
4.

Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults.

Schürmann D, Fätkenheuer G, Reynes J, Michelet C, Raffi F, van Lier J, Caceres M, Keung A, Sansone-Parsons A, Dunkle LM, Hoffmann C.

AIDS. 2007 Jun 19;21(10):1293-9.

PMID:
17545705
5.

Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.

Sansone-Parsons A, Krishna G, Martinho M, Kantesaria B, Gelone S, Mant TG.

Pharmacotherapy. 2007 Jun;27(6):825-34.

PMID:
17542765
6.

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.

Krishna G, Sansone-Parsons A, Martinho M, Kantesaria B, Pedicone L.

Antimicrob Agents Chemother. 2007 Mar;51(3):812-8. Epub 2007 Jan 8.

7.

Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.

Sansone-Parsons A, Krishna G, Simon J, Soni P, Kantesaria B, Herron J, Stoltz R.

Antimicrob Agents Chemother. 2007 Feb;51(2):495-502. Epub 2006 Nov 13.

8.

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.

Gubbins PO, Krishna G, Sansone-Parsons A, Penzak SR, Dong L, Martinho M, Anaissie EJ.

Antimicrob Agents Chemother. 2006 Jun;50(6):1993-9.

9.

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers.

Sansone-Parsons A, Krishna G, Calzetta A, Wexler D, Kantesaria B, Rosenberg MA, Saltzman MA.

Antimicrob Agents Chemother. 2006 May;50(5):1881-3.

Supplemental Content

Loading ...
Support Center